for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Healthcare

BRIEF-Caladrius Biosciences Announces $5.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

April 23 (Reuters) - Caladrius Biosciences Inc:

* CALADRIUS BIOSCIENCES ANNOUNCES $5.0 MILLION REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET UNDER NASDAQ RULES

* CALADRIUS BIOSCIENCES INC - AGREEMENTS FOR ISSUANCE AND SALE OF 2.2 MILLION SHARES OF COMMON STOCK AT $2.3125 PER SHARE

* CALADRIUS BIOSCIENCES INC - INTENDS TO USE NET PROCEEDS FROM OFFERING FOR ADVANCEMENT OF ITS CD34+ TECHNOLOGY-BASED CLINICAL PROGRAMS Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up